Clinical Trials Logo

Erectile Dysfunction clinical trials

View clinical trials related to Erectile Dysfunction.

Filter by:

NCT ID: NCT05735223 Completed - Clinical trials for Prostate Adenocarcinoma

A Prospective Study to Evaluate the Impact of Maximal Urethral Length Preservation Technique During Robotic Laparoscopic Prostatectomy on the Stretched Flaccid Penile Length and Continence

Start date: September 30, 2021
Phase: N/A
Study type: Interventional

After robotic prostatectomy, besides erectile function and achievement of oncological control, staying dry is also a very important desire expressed frequently by the patients. This has led to the concept of trifecta achievement after robotic prostatectomies. Hence, continence preserving prostatectomies are the order of the day today. Patient acceptance to surgery is low if the continence cannot be assured preoperatively. Many techniques have been promulgated in the last two decades. The investigators present a novel technique of maximal urethral length preservation during surgery as an effective method of continence preservation. The investigators hypothesize that maximal preservation of urethra would lead to improved and early continence after robotic prostatectomy. The investigators also hypothesize that urethral preservation spares penile length shortening. The investigators therefore propose to prospectively evaluate penile length shortening. While penile length change after radical prostatectomy has been studied in the past, the investigators like to assess the penile morphometric assessment following the novel technique of maximal urethral length preservation radical prostatectomy.

NCT ID: NCT05679999 Completed - Clinical trials for Erectile Dysfunction Due to Arterial Disease

Carotid Artery Intima Media Thickness Can Predict the Response to Phosphodiesterase 5 Inhibitors in the Patients With Moderate Erectile Dysfunction

Start date: January 1, 2018
Phase:
Study type: Observational

The aim of the present study was to examine the relationship between degrees of erectile dysfunction and carotid artery intima media thickness (CIMT) and its effect on the medical treatment of this disease. Considering that there are vascular pathologies in the etiology, it is important to reveal vascular disorders with CIMT, which is a non-invasive, easily applicable method, and to use it in the grading and treatment of erectile dysfunction.

NCT ID: NCT05585931 Completed - Clinical trials for Erectile Dysfunction

Effect of TPN171H on Spermatogenesis

Start date: November 15, 2022
Phase: Phase 1
Study type: Interventional

This study is a phaseâ… study to determine the acute effects of TPN171H on semen function in healthy male subjects.

NCT ID: NCT05462171 Completed - Clinical trials for Erectile Dysfunction

The Prevalence of Erectile Dysfunction (ED) and Premature Ejaculation (PE) in Poland

ED POLAND
Start date: July 1, 2022
Phase:
Study type: Observational

The first large population-based study to evaluate erectile dysfunction (ED) and premature ejaculation (PE) in Poland. The study objective is to assess the prevalence and bother of ED and PE in the representative group of male population of Poland.

NCT ID: NCT05446493 Completed - Clinical trials for Erectile Dysfunction

Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction

Start date: April 1, 2019
Phase: Phase 4
Study type: Interventional

The aim of this current study is to estimate serum level of YKL-40, serum total testosterone and platelets indices in diabetic patients with erectile dysfunction treated by daily tadalafil 5mg for 3 months.

NCT ID: NCT05388825 Completed - Clinical trials for Erectile Dysfunction

Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction

Start date: August 1, 2022
Phase: Phase 2
Study type: Interventional

This study is a randomized, double-blind, placebo-controlled, two-cohort, three-cycle crossover (at least a 5-day cleaning period per cycle), and a multicenter clinical trial design.

NCT ID: NCT05347329 Completed - Clinical trials for Erectile Dysfunction

A Clinical Trial to Investigate the Efficacy and Safety of Tongkat Ali Maca Plus

Start date: September 10, 2019
Phase: N/A
Study type: Interventional

This was a randomized, double blind, placebo-controlled, Three-arm, multicenter, parallel groups, interventional phase II clinical trial evaluating the efficacy, and safety of a herbal medicinal product of dried roots of Eurycoma longifolia Jack (Tongkat Ali) and dried tuberous roots of Lepidium meyenii (Maca) for the improvement of sexual well-being and quality of life in men.

NCT ID: NCT05332340 Completed - Prostate Cancer Clinical Trials

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

Start date: November 16, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate pharmacokinetics, safety and tolerability profile of BZ371A topically administered in healthy patients.

NCT ID: NCT05316428 Completed - Clinical trials for Erectile Dysfunction

A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects

Start date: February 24, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is primarily to evaluate the effects of taking TPN171H tablets with alcohol on blood pressure, pulse,and pharmacokinetic in Chinese healthy male subjects.

NCT ID: NCT05311748 Completed - Clinical trials for Erectile Dysfunction Due to Arterial Disease

Prospective Cross-sectional Evaluation of Penile Helicine Circulation in Veno-occlusive Erectile Dysfunction

PD and VOD
Start date: January 15, 2014
Phase:
Study type: Observational

Background: The aim of this study is to evaluate the usefulness of Power Doppler in order to improve the diagnostic work up of veno-occlusive erectile dysfunction patients. Materials and Methods: Two hundred and two patients affected by erectile dysfunction, mean IIEF 5 = 13.5 (12-17) for at least 6 months, were enrolled in a prospective cross-sectional study. All patients underwent Dynamic Power Doppler after intracevernous injection of vasoactive drugs. Poor responders patients subsequently underwent to cavernosometry to get a full assessment of the vascular framework.